Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.300
-0.050 (-2.13%)
Sep 4, 2026, 9:34 AM EDT - Market open
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $5.2 million as of September 4, 2026. Its market cap has decreased by -62.77% in one year.
Market Cap
5.20M
Enterprise Value
-3.78M
1-Year Change
-62.77%
Ranking
Category
Stock Price
$2.30
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $5.20M, a decrease of -71.88%. That is a compound annual growth rate of -6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 5.20M | -78.90% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 6.16M |
| Processa Pharmaceuticals | 5.73M |
| Kairos Pharma | 5.65M |
| Cardio Diagnostics Holdings | 5.42M |
| PharmaCyte Biotech | 5.27M |
| HCW Biologics | 5.27M |
| GRI Bio | 5.01M |
| Liminatus Pharma | 4.97M |